AMLX
Amylyx Pharmaceuticals Inc
33.00$
+1.9%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +338.0% | +648.8% | +270.6% | +32.2% | -62.6% | +71.8% | |
| – | +326.0% | +669.5% | +264.1% | +21.6% | -59.2% | +70.9% | |
| – | +320.1% | +289.8% | +24.6% | +172.2% | -54.5% | +192.9% | |
| – | +320.1% | +646.4% | +261.0% | +7.0% | -52.5% | +79.6% | |
| – | – | – | – | +161.7% | -98.9% | -80.3% | |
| – | – | – | – | +292.3% | -100.0% | – | |
| – | – | +213.9% | +450.8% | – | – | – | |
| – | +182.8% | +217.7% | -80.2% | +65.2% | -65.6% | -5.1% | |
| – | +61.8% | +137.5% | +167.9% | +76.0% | -65.4% | -20.1% | |
| – | – | – | – | +10.6% | -32.7% | -17.1% | |
| – | +64.6% | +21.0% | +43.1% | +252.6% | -86.7% | +19.7% | |
| – | -90.5% | – | – | – | – | – | |
| – | – | – | – | +27.3% | -62.0% | +85.3% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +2.5% | +14.9% | +5.2% | -2.6% | +38.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.